ARCANA INSTITUTE

A CERTARA COMPANY

Arcana Institute (INAR) is now part of Certara, a global leader in model-informed drug development and regulatory science.

Arcana Institute, together with Analytica Laser and other companies acquired by Certara, provides support for drug development through the product’s full life cycle, from clinical trial planning & design, drug registration, Real World Data, strategic support in HEOR and Market Access, up to reimbursement and beyond.

Certara’s staff includes over 700 experts in more than 20 offices worldwide!

Together, we are creating innovative analytical methods to provide our partners with the highest-quality scientific evidence in safety, clinical efficacy and effectiveness for medical technologies.

find out more

Business Partners

Cooperative Institutions

News

7 October 2020

Analysis of the Reimbursement Decision-Making Practice in Poland (September 2020)

The results include the notice of the Minister of Health, effective 1st of September 2020. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations  more...
28 February 2020

Analysis of the Reimbursement Decision-Making Practice in Poland (March 2020)

The results include the notice of the Minister of Health of 18 February 2020, effective 1st of March 2020. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements  more...
20 January 2020

Analysis of the Reimbursement Decision-Making Practice in Poland (January 2020)

The results include the notice of the Minister of Health of 20 December 2019, effective 1st of January 2020. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements  more...